Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Stopped No longer aligned with the revised clinical development plan and commercial strategy

Conditions

• Neoplasms
• Febrile Neutropenia

Interventions

• DRUG: CAZ-AVI
• DRUG: Vancomycin
• DRUG: Linezolid
• DRUG: Cefepime
• DRUG: Meropenem
• DRUG: Piperacillin/tazobactam

Sponsor

Forest Laboratories